HPV Infection
124
31
49
38
Key Insights
Highlights
Success Rate
97% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.8%
1 terminated out of 124 trials
97.4%
+10.9% vs benchmark
16%
20 trials in Phase 3/4
16%
6 of 38 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 38 completed trials
Clinical Trials (124)
Feasibility of HPV Self-Collection Kits for Cervical Cancer Screening
Evaluation of the Q-Pad hrHPV Test System for Identifying Precancer
Effect of EGCG, Folic Acid, Vitamin B12 and Hyaluronic Acid on HPV DNA Integration
Vaginal Self-sampling for Detecting High-risk Human Papillomavirus Cervical Infection in Patients With Immune-mediated Inflammatory Diseases
Assessing Administration of pBI-11 Via Electroporation for the Treatment of Patients With HPV16/18+
Non-Invasive Plasma Treatment for Cervical Infections: Targeting High- and Low-Risk HPV Variants
Cervical Pre-cancer Treatment Failure Among Women Living With HIV in Zimbabwe
Optimization of Cervical Cancer Screening Among Women Living With HIV in Latin American Countries
Nine-valent HPV Vaccine to Prevent Persistent Oral HPV Infection in Men Living With HIV
Immunogenicity and Safety of Sequential 2vHPV-9vHPV Vaccination in Girls Aged 9-14 Years
Clinic vs Clinic+Community Outreach HPV Self-Collection to Increase Cervical Screening in Women Living With HIV
Adjuvant 5-Fluorouracil Following Thermal Ablation to Improve HPV Treatment Outcomes in Women With HIV in Kenya
Clinic vs Clinic+Community Outreach HPV Self-Collection to Increase Cervical Screening in Women With HIV
ORCHID: An Online Intervention for Persons With HIV (Miami)
Game-Based Intervention to Promote HPV Vaccination
Early Phase Clinical Trial About Therapeutic Biological Product Mix for Treating HPV
PRIORITY Study in Cervical Cancer
Phase II Study of Dysplasix™ Intravaginal Suppositories in Patients Patients With High-Risk HPV and Mild Cervical Cytologic Abnormalities
Intradermal, Fractional Dose of HPV Vaccines:
Immunogenicity of Fractional Dose of the HPV Vaccines